Stock Track | Astrana Health Soars 18.25% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track03-02

Astrana Health's stock surged 18.25% during intraday trading on Monday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.

The healthcare management company reported adjusted earnings per share of $0.54 for Q4 2025, dramatically surpassing the FactSet consensus estimate of $0.11. Revenue for the quarter reached $950.5 million, also beating the estimated $930.5 million. For the full year 2025, the company reported total revenue of $3.2 billion, representing a 56% increase year-over-year.

Further fueling investor optimism, Astrana issued strong guidance for 2026, forecasting total revenue in the range of $3.8 billion to $4.1 billion, compared to the FactSet estimate of $3.96 billion. The company also announced that its board increased the share repurchase authorization to $100 million from $50 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147159596?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-02 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147159596","market":"sg","top_or_hot":-1,"title":"Stock Track | Astrana Health Soars 18.25% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance","media":"Stock Track","content":"<p>Astrana Health's stock surged 18.25% during intraday trading on Monday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.</p><p>The healthcare management company reported adjusted earnings per share of $0.54 for Q4 2025, dramatically surpassing the FactSet consensus estimate of $0.11. Revenue for the quarter reached $950.5 million, also beating the estimated $930.5 million. For the full year 2025, the company reported total revenue of $3.2 billion, representing a 56% increase year-over-year.</p><p>Further fueling investor optimism, Astrana issued strong guidance for 2026, forecasting total revenue in the range of $3.8 billion to $4.1 billion, compared to the FactSet estimate of $3.96 billion. The company also announced that its board increased the share repurchase authorization to $100 million from $50 million.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Astrana Health Soars 18.25% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Astrana Health Soars 18.25% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-02 22:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Astrana Health's stock surged 18.25% during intraday trading on Monday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.</p><p>The healthcare management company reported adjusted earnings per share of $0.54 for Q4 2025, dramatically surpassing the FactSet consensus estimate of $0.11. Revenue for the quarter reached $950.5 million, also beating the estimated $930.5 million. For the full year 2025, the company reported total revenue of $3.2 billion, representing a 56% increase year-over-year.</p><p>Further fueling investor optimism, Astrana issued strong guidance for 2026, forecasting total revenue in the range of $3.8 billion to $4.1 billion, compared to the FactSet estimate of $3.96 billion. The company also announced that its board increased the share repurchase authorization to $100 million from $50 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ASTH","symbol_name":"Astrana Health","start_time":0,"source_url":"","article_id":"1147159596","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147159596","pubTimestamp":1772462009,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Astrana Health's stock surged 18.25% during intraday trading on Monday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ASTH":"Astrana Health"},"translate_title":"股票追踪|Astrana Health盘中飙升18.25%，第四季度盈利强劲，2026年指引乐观","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASTH":1},"content_text":"Astrana Health's stock surged 18.25% during intraday trading on Monday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.The healthcare management company reported adjusted earnings per share of $0.54 for Q4 2025, dramatically surpassing the FactSet consensus estimate of $0.11. Revenue for the quarter reached $950.5 million, also beating the estimated $930.5 million. For the full year 2025, the company reported total revenue of $3.2 billion, representing a 56% increase year-over-year.Further fueling investor optimism, Astrana issued strong guidance for 2026, forecasting total revenue in the range of $3.8 billion to $4.1 billion, compared to the FactSet estimate of $3.96 billion. The company also announced that its board increased the share repurchase authorization to $100 million from $50 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147159596","isCrawlerRequest":true}